Milena Sokolowska Selected Research

Group IV Phospholipases A2

2/2014	Low molecular weight hyaluronan activates cytosolic phospholipase A2α and eicosanoid production in monocytes and macrophages.
1/2014	The step further to understand the role of cytosolic phospholipase A2 alpha and group X secretory phospholipase A2 in allergic inflammation: pilot study.
6/2010	Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Milena Sokolowska Research Topics

Disease

29	Asthma (Bronchial Asthma) 11/2022 - 12/2009
14	Hypersensitivity (Allergy) 10/2022 - 11/2012
12	Inflammation (Inflammations) 01/2022 - 01/2014
7	COVID-19 01/2022 - 01/2020
5	Atopic Dermatitis (Atopic Eczema) 11/2022 - 10/2017
4	Allergic Rhinitis 11/2022 - 01/2019
3	Anaphylaxis (Anaphylactic Shock) 12/2021 - 09/2021
3	Neoplasms (Cancer) 01/2021 - 06/2015
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2022
2	Infections 01/2022 - 10/2021
2	Food Hypersensitivity (Food Allergy) 12/2021 - 01/2019
2	Eosinophilia 09/2021 - 01/2019
2	Lung Diseases (Lung Disease) 01/2021 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 01/2014
1	Respiratory Hypersensitivity 01/2022
1	Drug Hypersensitivity (Drug Allergy) 12/2021
1	Chronic Urticaria 12/2021
1	Rhinosinusitis 12/2021
1	Dysbiosis 11/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Disease Progression 01/2021
1	Obesity 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Emphysema 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Lung Injury 01/2018
1	Pneumonia (Pneumonitis) 01/2018

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 01/2022 - 11/2012
6	CytokinesIBA 01/2022 - 01/2014
5	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2017
5	EicosanoidsIBA 01/2022 - 01/2014
5	VaccinesIBA 09/2021 - 11/2012
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2014
4	AllergensIBA 01/2017 - 11/2012
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2020
3	COVID-19 VaccinesIBA 10/2021 - 01/2021
3	InflammasomesIBA 10/2021 - 06/2015
3	LipidsIBA 01/2021 - 02/2014
3	Group IV Phospholipases A2IBA 02/2014 - 06/2010
2	InterferonsIBA 01/2022 - 09/2021
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 12/2015
2	LeukotrienesIBA 01/2021 - 12/2009
2	OzoneIBA 01/2019 - 01/2018
1	PrebioticsIBA 11/2022
1	Environmental BiomarkersIBA 10/2022
1	CannabinoidsIBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Vitamin A (Retinol)FDA LinkGeneric 01/2022
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2022
1	beta Carotene (Betacarotene)FDA Link 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	MicronutrientsIBA 01/2022
1	ZincIBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	Prostaglandin D2IBA 01/2022
1	IronIBA 01/2022
1	AntipyreticsIBA 01/2022
1	AlarminsIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2021
1	InterleukinsIBA 01/2021
1	Leukotriene Receptors (Leukotriene Receptor)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	prostaglandin D2 receptorIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	LipoxinsIBA 01/2021
1	ThromboxanesIBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	ProstaglandinsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AllergoidsIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	Pharmaceutical PreparationsIBA 10/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	TabletsIBA 01/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2019
1	SmokeIBA 01/2019
1	MucinsIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Interleukin-33IBA 01/2018
1	Tight Junction ProteinsIBA 01/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 08/2015
4	Precision Medicine 10/2022 - 10/2017
2	Immunotherapy 01/2022 - 01/2019
1	Injections 10/2021
1	Aftercare (After-Treatment) 01/2021
1	Contraindications 01/2021
1	Immunomodulation 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Oral Administration 01/2019